Posted inHematology-Oncology news
IDH3 as a Metabolic Checkpoint Modulating Venetoclax Resistance in AML Stem Cells
This article elucidates how the TCA cycle enzyme IDH3 critically regulates metabolic fitness in AML stem cells, influencing venetoclax resistance and offering a novel target to improve therapeutic outcomes.
